BTX-A application inhibits the evoked release of CGRP from afferent nerve terminals in isolated rat bladder. This finding suggests a potential clinical benefit of BTX-A for the treatment of interstitial cystitis or sensory urgency.
No takes yet. Share an insight, caveat, or question.
Rapp et al. (2006) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: